Evaluation of Systemic Blood Irradiation with Laser (ILIB) and Laser Therapy in the prevention and treatment of Saliva Loss in Cancer Patients

Phase 2

Recruiting

• Conditions: Changes in saliva secretion; Head and Neck Neoplasms; C07.465.815.929

• Registration Number: RBR-10fwcndv
• Lead Sponsor: Roberta Mariano de Carvalho e Silva

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-11-10
• Study Completion: 2022-06-30
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Volunteer patients; diagnosed with head and neck SCC; older than 18 years; in the 1st week of treatment with curative radiotherapy associated or not with chemotherapy.

Exclusion Criteria

Patients under 18 years of age; intubated; who did not start radiotherapy or chemoradiotherapy; palliatives for cancer treatment; with total loss of the maxilla or mandible due to the tumor.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluate xerostomia through the answer method of the Quality of Life Questionnaire developed and validated by the University of Michigan. A 20% reduction in the mean scores on the Questionnaire between the beginning and end of treatment will be considered clinically relevant.